TRANSLOCATION RENAL CELL CARCINOMA
Clinical trials for TRANSLOCATION RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new TRANSLOCATION RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for TRANSLOCATION RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Drug cocktail targets Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests whether a combination of three drugs (sasanlimab, palbociclib, and axitinib) can shrink tumors in people with advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 26, 2026 04:00 UTC
-
New drug combo offers hope for Hard-to-Treat kidney cancer
Disease control Recruiting nowThis study tests whether combining two drugs, abemaciclib and cabozantinib, is safe and works for people with advanced kidney cancer that has not responded to immunotherapy. About 43 adults with clear cell or translocation-associated kidney cancer will take part. Researchers will…
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New hope for rare cancers: immunotherapy trial targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control tumors for at least 12 months. About 28 adults who have not responded to standard treatments will take part.
Matched conditions: TRANSLOCATION RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated May 18, 2026 12:13 UTC